Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck (Q42644659)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck |
scientific article |
Statements
1 reference
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck (English)
1 reference
Olufunmilayo I Olopade
1 reference
Everett E Vokes
1 reference
Tanguy Y Seiwert
1 reference
Kerstin Stenson
1 reference
Ezra E W Cohen
1 reference
Cesar A Perez
1 reference
Hunho Song
1 reference
Luis E Raez
1 reference
Mark Agulnik
1 reference
Tatyana A Grushko
1 reference
Allison Dekker
1 reference
Elizabeth A Blair
1 reference
17 April 2012
1 reference
1 reference
48
1 reference
9
1 reference
887-892
1 reference
Identifiers
1 reference
1 reference